Glenmark Pharma on Wednesday announced the launch of its generic version of Nintedanib, used for the treatment of pulmonary fibrosis, in India. “Glenmark being a leader in the area of respiratory has been amongst the first to launch the branded generic version at an affordable cost for the treatment of pulmonary fibrosis in India,” it said in a regulatory filing. …
